Filtered By:
Source: Thrombosis and Haemostasis
Condition: Atrial Fibrillation

This page shows you your search results in order of relevance. This is page number 13.

Order by Relevance | Date

Total 186 results found since Jan 2013.

Elevated thrombin generation levels in the left atrial appendage in patients with atrial fibrillation
CONCLUSION: In patients with AF undergoing catheter ablation, the LAA demonstrated increased thrombin generation compared with the LA. This finding might contribute to the understanding of why the LAA is more predisposed to thrombus formation than the LA.CLINICAL TRIALS REGISTRATION: NCT03795883.PMID:37063762 | PMC:PMC10099305 | DOI:10.1016/j.rpth.2023.100127
Source: Thrombosis and Haemostasis - April 17, 2023 Category: Hematology Authors: Adi Elias Yara Khoury Faheem Shehadeh Gilat Ron Monther Boulos Jeries Nashashibi Robert Zukermann Mazen Elias Lior Gepstein Mahmoud Suleiman Source Type: research

von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction
CONCLUSION: Although low ADAMTS-13 predicted death, the cardiovascular risk associated with VWF and ADAMTS-13 was weaker than previously reported. Low VWF is associated with new-onset AF and needs further research.PMID:37255854 | PMC:PMC10225923 | DOI:10.1016/j.rpth.2023.100164
Source: Thrombosis and Haemostasis - May 31, 2023 Category: Hematology Authors: Ellen M K Warlo Are A Kalstad Peder L Myhre Svein Solheim Harald Arnesen Arnljot Tveit P ål Andre Holme Ingebj ørg Seljeflot Vibeke Bratseth Source Type: research

Warfarin faring better: Vitamin K antagonists beat rivaroxaban and apixaban in the INVICTUS and PROACT Xa trials
J Thromb Haemost. 2023 Jul 8:S1538-7836(23)00523-8. doi: 10.1016/j.jtha.2023.06.036. Online ahead of print.ABSTRACTAlthough guidelines give preference to the direct oral anticoagulants (DOACs) over vitamin K antagonists (VKAs) for stroke prevention in most patients with atrial fibrillation (AF), DOACs are not recommended in those with rheumatic heart disease or mechanical heart valves. The results of the INVICTUS trial (Investigation of Rheumatic AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies), which compared rivaroxaban with a VKA in patients with rheumatic heart disease associated AF, and the PR...
Source: Thrombosis and Haemostasis - July 10, 2023 Category: Hematology Authors: John W Eikelboom Jeffrey I Weitz Source Type: research